Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon

Descripción del Articulo

The measurement of recent malaria exposure can support malaria control efforts. This study evaluated serological responses to an in-house Plasmodium vivax Merozoite Surface Protein 8 (PvMSP8) expressed in a Baculovirus system as sero-marker of recent exposure to P. vivax (Pv) in the Peruvian Amazon....

Descripción completa

Detalles Bibliográficos
Autores: Villasis E., Garro K., Rosas-Aguirre A., Rodriguez P., Rosado J., Gave A., Guzman-Guzman M., Manrique P., White M., Speybroeck N., Vinetz J.M., Torres K., Gamboa D.
Formato: artículo
Fecha de Publicación:2021
Institución:Consejo Nacional de Ciencia Tecnología e Innovación
Repositorio:CONCYTEC-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.concytec.gob.pe:20.500.12390/2375
Enlace del recurso:https://hdl.handle.net/20.500.12390/2375
https://doi.org/10.3390/pathogens10030282
Nivel de acceso:acceso abierto
Materia:PvMSP8
Antibodies
ELISA
Luminex
Malaria
P. vivax
http://purl.org/pe-repo/ocde/ford#3.03.09
id CONC_5960bf548901b39bd103a8340799d1d0
oai_identifier_str oai:repositorio.concytec.gob.pe:20.500.12390/2375
network_acronym_str CONC
network_name_str CONCYTEC-Institucional
repository_id_str 4689
dc.title.none.fl_str_mv Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon
title Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon
spellingShingle Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon
Villasis E.
PvMSP8
Antibodies
ELISA
Luminex
Malaria
P. vivax
http://purl.org/pe-repo/ocde/ford#3.03.09
title_short Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon
title_full Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon
title_fullStr Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon
title_full_unstemmed Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon
title_sort Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon
author Villasis E.
author_facet Villasis E.
Garro K.
Rosas-Aguirre A.
Rodriguez P.
Rosado J.
Gave A.
Guzman-Guzman M.
Manrique P.
White M.
Speybroeck N.
Vinetz J.M.
Torres K.
Gamboa D.
author_role author
author2 Garro K.
Rosas-Aguirre A.
Rodriguez P.
Rosado J.
Gave A.
Guzman-Guzman M.
Manrique P.
White M.
Speybroeck N.
Vinetz J.M.
Torres K.
Gamboa D.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Villasis E.
Garro K.
Rosas-Aguirre A.
Rodriguez P.
Rosado J.
Gave A.
Guzman-Guzman M.
Manrique P.
White M.
Speybroeck N.
Vinetz J.M.
Torres K.
Gamboa D.
dc.subject.none.fl_str_mv PvMSP8
topic PvMSP8
Antibodies
ELISA
Luminex
Malaria
P. vivax
http://purl.org/pe-repo/ocde/ford#3.03.09
dc.subject.es_PE.fl_str_mv Antibodies
ELISA
Luminex
Malaria
P. vivax
dc.subject.ocde.none.fl_str_mv http://purl.org/pe-repo/ocde/ford#3.03.09
description The measurement of recent malaria exposure can support malaria control efforts. This study evaluated serological responses to an in-house Plasmodium vivax Merozoite Surface Protein 8 (PvMSP8) expressed in a Baculovirus system as sero-marker of recent exposure to P. vivax (Pv) in the Peruvian Amazon. In a first evaluation, IgGs against PvMSP8 and PvMSP10 proteins were measured by Luminex in a cohort of 422 Amazonian individuals with known history of Pv exposure (monthly data of infection status by qPCR and/or microscopy over five months). Both serological responses were able to discriminate between exposed and non-exposed individuals in a good manner, with slightly higher performance of anti-PvMSP10 IgGs (area under the curve AUC = 0.78 [95% CI = 0.72–0.83]) than anti-PvMSP8 IgGs (AUC = 0.72 [95% CI = 0.67–0.78]) (p = 0.01). In a second evaluation, the analysis by ELISA of 1251 plasma samples, collected during a population-based cross-sectional survey, confirmed the good performance of anti-PvMSP8 IgGs for discriminating between individuals with Pv infection at the time of survey and/or with antecedent of Pv in the past month (AUC = 0.79 [95% CI = 0.74–0.83]). Anti-PvMSP8 IgG antibodies can be considered as a good biomarker of recent Pv exposure in low-moderate transmission settings of the Peruvian Amazon. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.available.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.issued.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.citation.none.fl_str_mv Villasis, E., Garro, K., Rosas-Aguirre, A., Rodriguez, P., Rosado, J., Gave, A., Guzman-Guzman, M., Manrique, P., White, M., Speybroeck, N., Vinetz, J. M., Torres, K., & Gamboa, D. (2021). PvMSP8 as a Novel Plasmodium vivax Malaria Sero-Marker for the Peruvian Amazon. Pathogens, 10(3), 282. https://doi.org/10.3390/pathogens10030282
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12390/2375
dc.identifier.doi.none.fl_str_mv https://doi.org/10.3390/pathogens10030282
dc.identifier.scopus.none.fl_str_mv 2-s2.0-85102554474
identifier_str_mv Villasis, E., Garro, K., Rosas-Aguirre, A., Rodriguez, P., Rosado, J., Gave, A., Guzman-Guzman, M., Manrique, P., White, M., Speybroeck, N., Vinetz, J. M., Torres, K., & Gamboa, D. (2021). PvMSP8 as a Novel Plasmodium vivax Malaria Sero-Marker for the Peruvian Amazon. Pathogens, 10(3), 282. https://doi.org/10.3390/pathogens10030282
2-s2.0-85102554474
url https://hdl.handle.net/20.500.12390/2375
https://doi.org/10.3390/pathogens10030282
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Pathogens
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.publisher.none.fl_str_mv MDPI AG
publisher.none.fl_str_mv MDPI AG
dc.source.none.fl_str_mv reponame:CONCYTEC-Institucional
instname:Consejo Nacional de Ciencia Tecnología e Innovación
instacron:CONCYTEC
instname_str Consejo Nacional de Ciencia Tecnología e Innovación
instacron_str CONCYTEC
institution CONCYTEC
reponame_str CONCYTEC-Institucional
collection CONCYTEC-Institucional
bitstream.url.fl_str_mv https://repositorio.concytec.gob.pe/bitstreams/ac2419d2-496c-4730-8fde-8b01a1bdc6b5/download
https://repositorio.concytec.gob.pe/bitstreams/9886a890-781b-45a6-9e98-87634b2be6cc/download
https://repositorio.concytec.gob.pe/bitstreams/43bf56c2-1d86-419f-88ee-0b239c237214/download
bitstream.checksum.fl_str_mv 89fa125b69798e754ce5d1c19491d424
c1bc401105ef9ba4de280dba674bda8c
28b872a639e65f5823689d59025327db
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional CONCYTEC
repository.mail.fl_str_mv repositorio@concytec.gob.pe
_version_ 1844883125623062528
spelling Publicationrp05771600rp05768600rp01119600rp05770600rp05764600rp01537600rp05767600rp01535600rp05766600rp01120600rp05765600rp05769600rp01117600Villasis E.Garro K.Rosas-Aguirre A.Rodriguez P.Rosado J.Gave A.Guzman-Guzman M.Manrique P.White M.Speybroeck N.Vinetz J.M.Torres K.Gamboa D.2024-05-30T23:13:38Z2024-05-30T23:13:38Z2021Villasis, E., Garro, K., Rosas-Aguirre, A., Rodriguez, P., Rosado, J., Gave, A., Guzman-Guzman, M., Manrique, P., White, M., Speybroeck, N., Vinetz, J. M., Torres, K., & Gamboa, D. (2021). PvMSP8 as a Novel Plasmodium vivax Malaria Sero-Marker for the Peruvian Amazon. Pathogens, 10(3), 282. https://doi.org/10.3390/pathogens10030282https://hdl.handle.net/20.500.12390/2375https://doi.org/10.3390/pathogens100302822-s2.0-85102554474The measurement of recent malaria exposure can support malaria control efforts. This study evaluated serological responses to an in-house Plasmodium vivax Merozoite Surface Protein 8 (PvMSP8) expressed in a Baculovirus system as sero-marker of recent exposure to P. vivax (Pv) in the Peruvian Amazon. In a first evaluation, IgGs against PvMSP8 and PvMSP10 proteins were measured by Luminex in a cohort of 422 Amazonian individuals with known history of Pv exposure (monthly data of infection status by qPCR and/or microscopy over five months). Both serological responses were able to discriminate between exposed and non-exposed individuals in a good manner, with slightly higher performance of anti-PvMSP10 IgGs (area under the curve AUC = 0.78 [95% CI = 0.72–0.83]) than anti-PvMSP8 IgGs (AUC = 0.72 [95% CI = 0.67–0.78]) (p = 0.01). In a second evaluation, the analysis by ELISA of 1251 plasma samples, collected during a population-based cross-sectional survey, confirmed the good performance of anti-PvMSP8 IgGs for discriminating between individuals with Pv infection at the time of survey and/or with antecedent of Pv in the past month (AUC = 0.79 [95% CI = 0.74–0.83]). Anti-PvMSP8 IgG antibodies can be considered as a good biomarker of recent Pv exposure in low-moderate transmission settings of the Peruvian Amazon. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengMDPI AGPathogensinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/PvMSP8Antibodies-1ELISA-1Luminex-1Malaria-1P. vivax-1http://purl.org/pe-repo/ocde/ford#3.03.09-1Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazoninfo:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTECORIGINALPvMSP8 - pathogens.pdfPvMSP8 - pathogens.pdfapplication/pdf3240437https://repositorio.concytec.gob.pe/bitstreams/ac2419d2-496c-4730-8fde-8b01a1bdc6b5/download89fa125b69798e754ce5d1c19491d424MD51TEXTPvMSP8 - pathogens.pdf.txtPvMSP8 - pathogens.pdf.txtExtracted texttext/plain95313https://repositorio.concytec.gob.pe/bitstreams/9886a890-781b-45a6-9e98-87634b2be6cc/downloadc1bc401105ef9ba4de280dba674bda8cMD52THUMBNAILPvMSP8 - pathogens.pdf.jpgPvMSP8 - pathogens.pdf.jpgGenerated Thumbnailimage/jpeg5842https://repositorio.concytec.gob.pe/bitstreams/43bf56c2-1d86-419f-88ee-0b239c237214/download28b872a639e65f5823689d59025327dbMD5320.500.12390/2375oai:repositorio.concytec.gob.pe:20.500.12390/23752025-01-19 22:00:34.376https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessopen accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="7434d58c-e73b-48a8-af26-182bddcfcc8d"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Pvmsp8 as a novel plasmodium vivax malaria sero-marker for the peruvian amazon</Title> <PublishedIn> <Publication> <Title>Pathogens</Title> </Publication> </PublishedIn> <PublicationDate>2021</PublicationDate> <DOI>https://doi.org/10.3390/pathogens10030282</DOI> <SCP-Number>2-s2.0-85102554474</SCP-Number> <Authors> <Author> <DisplayName>Villasis E.</DisplayName> <Person id="rp05771" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Garro K.</DisplayName> <Person id="rp05768" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Rosas-Aguirre A.</DisplayName> <Person id="rp01119" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Rodriguez P.</DisplayName> <Person id="rp05770" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Rosado J.</DisplayName> <Person id="rp05764" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Gave A.</DisplayName> <Person id="rp01537" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Guzman-Guzman M.</DisplayName> <Person id="rp05767" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Manrique P.</DisplayName> <Person id="rp01535" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>White M.</DisplayName> <Person id="rp05766" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Speybroeck N.</DisplayName> <Person id="rp01120" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Vinetz J.M.</DisplayName> <Person id="rp05765" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Torres K.</DisplayName> <Person id="rp05769" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Gamboa D.</DisplayName> <Person id="rp01117" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>MDPI AG</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by/4.0/</License> <Keyword>PvMSP8</Keyword> <Keyword>Antibodies</Keyword> <Keyword>ELISA</Keyword> <Keyword>Luminex</Keyword> <Keyword>Malaria</Keyword> <Keyword>P. vivax</Keyword> <Abstract>The measurement of recent malaria exposure can support malaria control efforts. This study evaluated serological responses to an in-house Plasmodium vivax Merozoite Surface Protein 8 (PvMSP8) expressed in a Baculovirus system as sero-marker of recent exposure to P. vivax (Pv) in the Peruvian Amazon. In a first evaluation, IgGs against PvMSP8 and PvMSP10 proteins were measured by Luminex in a cohort of 422 Amazonian individuals with known history of Pv exposure (monthly data of infection status by qPCR and/or microscopy over five months). Both serological responses were able to discriminate between exposed and non-exposed individuals in a good manner, with slightly higher performance of anti-PvMSP10 IgGs (area under the curve AUC = 0.78 [95% CI = 0.72–0.83]) than anti-PvMSP8 IgGs (AUC = 0.72 [95% CI = 0.67–0.78]) (p = 0.01). In a second evaluation, the analysis by ELISA of 1251 plasma samples, collected during a population-based cross-sectional survey, confirmed the good performance of anti-PvMSP8 IgGs for discriminating between individuals with Pv infection at the time of survey and/or with antecedent of Pv in the past month (AUC = 0.79 [95% CI = 0.74–0.83]). Anti-PvMSP8 IgG antibodies can be considered as a good biomarker of recent Pv exposure in low-moderate transmission settings of the Peruvian Amazon. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1
score 13.395896
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).